List of Tables
Table 1. Global Gene Therapy-based Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Viral Gene Delivery System
Table 3. Key Players of Non-viral Gene Delivery System
Table 4. Global Gene Therapy-based Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Gene Therapy-based Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Gene Therapy-based Drug Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Gene Therapy-based Drug Market Share by Region (2020-2025)
Table 8. Global Gene Therapy-based Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Gene Therapy-based Drug Market Share by Region (2026-2031)
Table 10. Gene Therapy-based Drug Market Trends
Table 11. Gene Therapy-based Drug Market Drivers
Table 12. Gene Therapy-based Drug Market Challenges
Table 13. Gene Therapy-based Drug Market Restraints
Table 14. Global Gene Therapy-based Drug Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Gene Therapy-based Drug Market Share by Players (2020-2025)
Table 16. Global Top Gene Therapy-based Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy-based Drug as of 2024)
Table 17. Ranking of Global Top Gene Therapy-based Drug Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Gene Therapy-based Drug Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Gene Therapy-based Drug, Headquarters and Area Served
Table 20. Global Key Players of Gene Therapy-based Drug, Product and Application
Table 21. Global Key Players of Gene Therapy-based Drug, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Gene Therapy-based Drug Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Gene Therapy-based Drug Revenue Market Share by Type (2020-2025)
Table 25. Global Gene Therapy-based Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Gene Therapy-based Drug Revenue Market Share by Type (2026-2031)
Table 27. Global Gene Therapy-based Drug Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Gene Therapy-based Drug Revenue Market Share by Application (2020-2025)
Table 29. Global Gene Therapy-based Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Gene Therapy-based Drug Revenue Market Share by Application (2026-2031)
Table 31. North America Gene Therapy-based Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Gene Therapy-based Drug Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Gene Therapy-based Drug Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Gene Therapy-based Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Gene Therapy-based Drug Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Gene Therapy-based Drug Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Gene Therapy-based Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Gene Therapy-based Drug Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Gene Therapy-based Drug Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Gene Therapy-based Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Gene Therapy-based Drug Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Gene Therapy-based Drug Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Gene Therapy-based Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Gene Therapy-based Drug Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Gene Therapy-based Drug Market Size by Country (2026-2031) & (US$ Million)
Table 46. Biogen Company Details
Table 47. Biogen Business Overview
Table 48. Biogen Gene Therapy-based Drug Product
Table 49. Biogen Revenue in Gene Therapy-based Drug Business (2020-2025) & (US$ Million)
Table 50. Biogen Recent Development
Table 51. Novartis Company Details
Table 52. Novartis Business Overview
Table 53. Novartis Gene Therapy-based Drug Product
Table 54. Novartis Revenue in Gene Therapy-based Drug Business (2020-2025) & (US$ Million)
Table 55. Novartis Recent Development
Table 56. Gilead Sciences Company Details
Table 57. Gilead Sciences Business Overview
Table 58. Gilead Sciences Gene Therapy-based Drug Product
Table 59. Gilead Sciences Revenue in Gene Therapy-based Drug Business (2020-2025) & (US$ Million)
Table 60. Gilead Sciences Recent Development
Table 61. Sarepta Therapeutics Company Details
Table 62. Sarepta Therapeutics Business Overview
Table 63. Sarepta Therapeutics Gene Therapy-based Drug Product
Table 64. Sarepta Therapeutics Revenue in Gene Therapy-based Drug Business (2020-2025) & (US$ Million)
Table 65. Sarepta Therapeutics Recent Development
Table 66. Alnylam Pharmaceuticals Company Details
Table 67. Alnylam Pharmaceuticals Business Overview
Table 68. Alnylam Pharmaceuticals Gene Therapy-based Drug Product
Table 69. Alnylam Pharmaceuticals Revenue in Gene Therapy-based Drug Business (2020-2025) & (US$ Million)
Table 70. Alnylam Pharmaceuticals Recent Development
Table 71. Amgen Company Details
Table 72. Amgen Business Overview
Table 73. Amgen Gene Therapy-based Drug Product
Table 74. Amgen Revenue in Gene Therapy-based Drug Business (2020-2025) & (US$ Million)
Table 75. Amgen Recent Development
Table 76. Spark Therapeutics Company Details
Table 77. Spark Therapeutics Business Overview
Table 78. Spark Therapeutics Gene Therapy-based Drug Product
Table 79. Spark Therapeutics Revenue in Gene Therapy-based Drug Business (2020-2025) & (US$ Million)
Table 80. Spark Therapeutics Recent Development
Table 81. Akcea Therapeutics Company Details
Table 82. Akcea Therapeutics Business Overview
Table 83. Akcea Therapeutics Gene Therapy-based Drug Product
Table 84. Akcea Therapeutics Revenue in Gene Therapy-based Drug Business (2020-2025) & (US$ Million)
Table 85. Akcea Therapeutics Recent Development
Table 86. bluebird bio Company Details
Table 87. bluebird bio Business Overview
Table 88. bluebird bio Gene Therapy-based Drug Product
Table 89. bluebird bio Revenue in Gene Therapy-based Drug Business (2020-2025) & (US$ Million)
Table 90. bluebird bio Recent Development
Table 91. Sunway Biotech Company Details
Table 92. Sunway Biotech Business Overview
Table 93. Sunway Biotech Gene Therapy-based Drug Product
Table 94. Sunway Biotech Revenue in Gene Therapy-based Drug Business (2020-2025) & (US$ Million)
Table 95. Sunway Biotech Recent Development
Table 96. SIBIONO Company Details
Table 97. SIBIONO Business Overview
Table 98. SIBIONO Gene Therapy-based Drug Product
Table 99. SIBIONO Revenue in Gene Therapy-based Drug Business (2020-2025) & (US$ Million)
Table 100. SIBIONO Recent Development
Table 101. AnGes Company Details
Table 102. AnGes Business Overview
Table 103. AnGes Gene Therapy-based Drug Product
Table 104. AnGes Revenue in Gene Therapy-based Drug Business (2020-2025) & (US$ Million)
Table 105. AnGes Recent Development
Table 106. Orchard Therapeutics Company Details
Table 107. Orchard Therapeutics Business Overview
Table 108. Orchard Therapeutics Gene Therapy-based Drug Product
Table 109. Orchard Therapeutics Revenue in Gene Therapy-based Drug Business (2020-2025) & (US$ Million)
Table 110. Orchard Therapeutics Recent Development
Table 111. Human Stem Cells Institute Company Details
Table 112. Human Stem Cells Institute Business Overview
Table 113. Human Stem Cells Institute Gene Therapy-based Drug Product
Table 114. Human Stem Cells Institute Revenue in Gene Therapy-based Drug Business (2020-2025) & (US$ Million)
Table 115. Human Stem Cells Institute Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
Table 119. Authors List of This Report
List of Figures
Figure 1. Gene Therapy-based Drug Picture
Figure 2. Global Gene Therapy-based Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Gene Therapy-based Drug Market Share by Type: 2024 VS 2031
Figure 4. Viral Gene Delivery System Features
Figure 5. Non-viral Gene Delivery System Features
Figure 6. Global Gene Therapy-based Drug Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Gene Therapy-based Drug Market Share by Application: 2024 VS 2031
Figure 8. Neurological Diseases Case Studies
Figure 9. Cancer Case Studies
Figure 10. Other Case Studies
Figure 11. Gene Therapy-based Drug Report Years Considered
Figure 12. Global Gene Therapy-based Drug Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Gene Therapy-based Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Gene Therapy-based Drug Market Share by Region: 2024 VS 2031
Figure 15. Global Gene Therapy-based Drug Market Share by Players in 2024
Figure 16. Global Top Gene Therapy-based Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy-based Drug as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Gene Therapy-based Drug Revenue in 2024
Figure 18. North America Gene Therapy-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Gene Therapy-based Drug Market Share by Country (2020-2031)
Figure 20. United States Gene Therapy-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Gene Therapy-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Gene Therapy-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Gene Therapy-based Drug Market Share by Country (2020-2031)
Figure 24. Germany Gene Therapy-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Gene Therapy-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Gene Therapy-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Gene Therapy-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Gene Therapy-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Gene Therapy-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Gene Therapy-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Gene Therapy-based Drug Market Share by Region (2020-2031)
Figure 32. China Gene Therapy-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Gene Therapy-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Gene Therapy-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Gene Therapy-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Gene Therapy-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Gene Therapy-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Gene Therapy-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Gene Therapy-based Drug Market Share by Country (2020-2031)
Figure 40. Mexico Gene Therapy-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Gene Therapy-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Gene Therapy-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Gene Therapy-based Drug Market Share by Country (2020-2031)
Figure 44. Turkey Gene Therapy-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Gene Therapy-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Gene Therapy-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Biogen Revenue Growth Rate in Gene Therapy-based Drug Business (2020-2025)
Figure 48. Novartis Revenue Growth Rate in Gene Therapy-based Drug Business (2020-2025)
Figure 49. Gilead Sciences Revenue Growth Rate in Gene Therapy-based Drug Business (2020-2025)
Figure 50. Sarepta Therapeutics Revenue Growth Rate in Gene Therapy-based Drug Business (2020-2025)
Figure 51. Alnylam Pharmaceuticals Revenue Growth Rate in Gene Therapy-based Drug Business (2020-2025)
Figure 52. Amgen Revenue Growth Rate in Gene Therapy-based Drug Business (2020-2025)
Figure 53. Spark Therapeutics Revenue Growth Rate in Gene Therapy-based Drug Business (2020-2025)
Figure 54. Akcea Therapeutics Revenue Growth Rate in Gene Therapy-based Drug Business (2020-2025)
Figure 55. bluebird bio Revenue Growth Rate in Gene Therapy-based Drug Business (2020-2025)
Figure 56. Sunway Biotech Revenue Growth Rate in Gene Therapy-based Drug Business (2020-2025)
Figure 57. SIBIONO Revenue Growth Rate in Gene Therapy-based Drug Business (2020-2025)
Figure 58. AnGes Revenue Growth Rate in Gene Therapy-based Drug Business (2020-2025)
Figure 59. Orchard Therapeutics Revenue Growth Rate in Gene Therapy-based Drug Business (2020-2025)
Figure 60. Human Stem Cells Institute Revenue Growth Rate in Gene Therapy-based Drug Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
